Werewolf Therapeutics Inc (HOWL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $47.64M
Last updated: Nov 17, 2026 at 11:05 AM ET
Werewolf Therapeutics Inc (HOWL) Stock Forecast
Analysts expect Werewolf Therapeutics (HOWL) to earn -$0.89 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.59.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$0.89
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.59
- EPS consensus
- Next report
- Mar 22, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.89 | -$0.89 to -$0.89 | 1 |
| Dec 31, 2027 | -$0.59 | -$0.59 to -$0.59 | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.17 | N/A | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
EPS Trend
The EPS consensus for the fiscal year ending Dec 31, 2026 is where it was 90 days ago.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.89 | -$1.27 | -$1.27 | N/A | -$0.89 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.59 | N/A | N/A | N/A | -$0.99 | N/A |
Frequently Asked Questions About HOWL
What is the HOWL stock forecast?
Consensus analyst estimates put Werewolf Therapeutics's EPS at -$0.89 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from HOWL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.89, with estimates from -$0.89 to -$0.89 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.59, with estimates from -$0.59 to -$0.59 from 1 analyst.
How many analysts cover HOWL?
1 analyst estimates EPS for Werewolf Therapeutics for the fiscal year ending Dec 31, 2026.
HOWL pages: Overview, Earnings, Forecast, Financials, Competitors